Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 117 | 2025 | 6670 | 6.550 |
Why?
|
Carbon Radioisotopes | 38 | 2020 | 567 | 4.720 |
Why?
|
Histone Deacetylases | 19 | 2024 | 717 | 3.880 |
Why?
|
Radiopharmaceuticals | 39 | 2025 | 2734 | 3.430 |
Why?
|
Brain | 83 | 2025 | 27454 | 2.660 |
Why?
|
Adamantane | 8 | 2022 | 148 | 2.370 |
Why?
|
Hydroxamic Acids | 12 | 2022 | 482 | 2.130 |
Why?
|
Neurosciences | 5 | 2023 | 385 | 1.880 |
Why?
|
Receptors, GABA | 17 | 2024 | 313 | 1.870 |
Why?
|
Histone Deacetylase Inhibitors | 14 | 2022 | 775 | 1.870 |
Why?
|
Fluorine Radioisotopes | 20 | 2025 | 424 | 1.800 |
Why?
|
Diterpenes, Clerodane | 5 | 2024 | 42 | 1.670 |
Why?
|
Papio | 19 | 2017 | 672 | 1.450 |
Why?
|
Receptors, Opioid, kappa | 3 | 2018 | 138 | 1.310 |
Why?
|
Azepines | 4 | 2016 | 329 | 1.240 |
Why?
|
Hallucinogens | 4 | 2024 | 207 | 1.190 |
Why?
|
Palladium | 4 | 2017 | 67 | 1.160 |
Why?
|
Autistic Disorder | 4 | 2023 | 1240 | 1.040 |
Why?
|
Dopamine | 11 | 2024 | 1617 | 0.990 |
Why?
|
Pyrrolidines | 3 | 2018 | 340 | 0.950 |
Why?
|
Isotope Labeling | 6 | 2020 | 395 | 0.930 |
Why?
|
Rats, Sprague-Dawley | 18 | 2022 | 8199 | 0.890 |
Why?
|
Levivirus | 6 | 2008 | 14 | 0.830 |
Why?
|
Neuroglia | 7 | 2019 | 960 | 0.800 |
Why?
|
Neurodegenerative Diseases | 2 | 2022 | 1094 | 0.800 |
Why?
|
Epigenesis, Genetic | 11 | 2024 | 3827 | 0.800 |
Why?
|
Capsid | 7 | 2011 | 435 | 0.790 |
Why?
|
Acetamides | 8 | 2024 | 260 | 0.790 |
Why?
|
Radioactive Tracers | 5 | 2017 | 68 | 0.780 |
Why?
|
Epigenomics | 5 | 2022 | 959 | 0.770 |
Why?
|
Benzamides | 8 | 2018 | 1380 | 0.770 |
Why?
|
Amyotrophic Lateral Sclerosis | 10 | 2022 | 1473 | 0.760 |
Why?
|
Rats | 27 | 2025 | 23835 | 0.740 |
Why?
|
Organometallic Compounds | 6 | 2015 | 648 | 0.690 |
Why?
|
Neurochemistry | 2 | 2019 | 29 | 0.680 |
Why?
|
Autoradiography | 4 | 2018 | 732 | 0.680 |
Why?
|
Alzheimer Disease | 8 | 2022 | 8747 | 0.620 |
Why?
|
Tissue Distribution | 15 | 2025 | 2299 | 0.610 |
Why?
|
Magnetic Resonance Imaging | 44 | 2024 | 36849 | 0.600 |
Why?
|
N-Methylaspartate | 1 | 2018 | 231 | 0.600 |
Why?
|
Neurofibrillary Tangles | 1 | 2020 | 459 | 0.590 |
Why?
|
Macrocyclic Compounds | 1 | 2018 | 67 | 0.590 |
Why?
|
Animals | 80 | 2025 | 169337 | 0.570 |
Why?
|
Olfactory Nerve | 1 | 2017 | 21 | 0.570 |
Why?
|
Histone Deacetylase 1 | 6 | 2022 | 133 | 0.560 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.560 |
Why?
|
Cyanides | 1 | 2017 | 82 | 0.550 |
Why?
|
Papio anubis | 8 | 2018 | 23 | 0.550 |
Why?
|
Prefrontal Cortex | 5 | 2024 | 2257 | 0.540 |
Why?
|
Receptors, Dopamine D1 | 2 | 2016 | 293 | 0.530 |
Why?
|
Phenylenediamines | 2 | 2013 | 88 | 0.520 |
Why?
|
Molecular Structure | 12 | 2019 | 1884 | 0.520 |
Why?
|
Monoacylglycerol Lipases | 1 | 2016 | 30 | 0.520 |
Why?
|
Neuralgia | 1 | 2022 | 622 | 0.520 |
Why?
|
Olfactory Pathways | 1 | 2017 | 133 | 0.510 |
Why?
|
Carbamates | 3 | 2016 | 192 | 0.500 |
Why?
|
Blast Injuries | 3 | 2024 | 324 | 0.500 |
Why?
|
Phosphines | 1 | 2015 | 18 | 0.490 |
Why?
|
Receptors, Serotonin | 2 | 2020 | 211 | 0.480 |
Why?
|
Serotonin 5-HT2 Receptor Antagonists | 1 | 2014 | 25 | 0.470 |
Why?
|
Indoles | 3 | 2015 | 1825 | 0.460 |
Why?
|
Psychomotor Disorders | 1 | 2015 | 149 | 0.460 |
Why?
|
Mental Disorders | 4 | 2023 | 6876 | 0.460 |
Why?
|
Olfaction Disorders | 1 | 2017 | 226 | 0.460 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1169 | 0.450 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2013 | 31 | 0.440 |
Why?
|
Drug Delivery Systems | 5 | 2024 | 2237 | 0.440 |
Why?
|
Low Back Pain | 4 | 2024 | 989 | 0.440 |
Why?
|
Raclopride | 9 | 2023 | 102 | 0.430 |
Why?
|
Receptors, Dopamine D2 | 7 | 2021 | 487 | 0.430 |
Why?
|
Aldehydes | 1 | 2014 | 170 | 0.420 |
Why?
|
Serotonin Receptor Agonists | 1 | 2014 | 151 | 0.420 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2012 | 42 | 0.420 |
Why?
|
Tauopathies | 1 | 2017 | 328 | 0.420 |
Why?
|
Capsid Proteins | 2 | 2008 | 468 | 0.420 |
Why?
|
Tritium | 1 | 2013 | 707 | 0.420 |
Why?
|
Protein Isoforms | 2 | 2016 | 1703 | 0.400 |
Why?
|
Fluorobenzenes | 1 | 2014 | 179 | 0.400 |
Why?
|
Platinum Compounds | 1 | 2012 | 95 | 0.400 |
Why?
|
Fingers | 1 | 2015 | 512 | 0.390 |
Why?
|
Halogenation | 7 | 2022 | 46 | 0.390 |
Why?
|
Binding, Competitive | 4 | 2018 | 1142 | 0.380 |
Why?
|
Amides | 1 | 2014 | 452 | 0.380 |
Why?
|
Pyridines | 9 | 2024 | 2889 | 0.370 |
Why?
|
Biological Assay | 1 | 2014 | 627 | 0.370 |
Why?
|
Dacarbazine | 2 | 2016 | 560 | 0.360 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3836 | 0.360 |
Why?
|
Metergoline | 1 | 2010 | 3 | 0.360 |
Why?
|
Central Nervous System | 2 | 2016 | 1346 | 0.360 |
Why?
|
Meninges | 2 | 2024 | 197 | 0.360 |
Why?
|
Histone Deacetylase 2 | 4 | 2019 | 72 | 0.350 |
Why?
|
Humans | 110 | 2025 | 768393 | 0.350 |
Why?
|
Fluorides | 4 | 2015 | 134 | 0.350 |
Why?
|
Antibodies | 2 | 2018 | 2425 | 0.340 |
Why?
|
Sex Characteristics | 2 | 2024 | 2660 | 0.340 |
Why?
|
Military Personnel | 3 | 2024 | 1266 | 0.340 |
Why?
|
Administration, Intranasal | 2 | 2024 | 485 | 0.340 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1141 | 0.330 |
Why?
|
Radiochemistry | 5 | 2020 | 50 | 0.330 |
Why?
|
Nitriles | 1 | 2015 | 984 | 0.330 |
Why?
|
Male | 70 | 2025 | 364902 | 0.330 |
Why?
|
Receptors, Dopamine D3 | 5 | 2022 | 109 | 0.330 |
Why?
|
Aminopyridines | 1 | 2013 | 580 | 0.320 |
Why?
|
Kinetics | 7 | 2021 | 6333 | 0.320 |
Why?
|
Central Nervous System Agents | 1 | 2009 | 73 | 0.320 |
Why?
|
Primates | 6 | 2021 | 521 | 0.310 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 618 | 0.310 |
Why?
|
Amyloid beta-Peptides | 2 | 2022 | 3910 | 0.310 |
Why?
|
Carbon Dioxide | 2 | 2013 | 1149 | 0.310 |
Why?
|
Temperature | 2 | 2015 | 2235 | 0.310 |
Why?
|
Diterpenes | 1 | 2009 | 170 | 0.310 |
Why?
|
Neurotransmitter Agents | 3 | 2019 | 665 | 0.310 |
Why?
|
Inflammation | 8 | 2020 | 10863 | 0.310 |
Why?
|
Sulfonamides | 3 | 2020 | 1980 | 0.300 |
Why?
|
Molecular Imaging | 2 | 2019 | 827 | 0.290 |
Why?
|
Fluorine | 3 | 2022 | 83 | 0.290 |
Why?
|
Anti-Anxiety Agents | 1 | 2010 | 405 | 0.280 |
Why?
|
Placebo Effect | 2 | 2024 | 518 | 0.280 |
Why?
|
Pyrimidines | 6 | 2020 | 3048 | 0.280 |
Why?
|
Migraine with Aura | 2 | 2020 | 204 | 0.280 |
Why?
|
Peptides | 2 | 2017 | 4353 | 0.280 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2258 | 0.280 |
Why?
|
Piperidines | 2 | 2017 | 1659 | 0.270 |
Why?
|
Brain Mapping | 8 | 2024 | 6740 | 0.260 |
Why?
|
Formaldehyde | 1 | 2008 | 361 | 0.260 |
Why?
|
Models, Neurological | 5 | 2019 | 1783 | 0.260 |
Why?
|
Visual Perception | 1 | 2014 | 1406 | 0.250 |
Why?
|
Sensory Receptor Cells | 2 | 2022 | 508 | 0.250 |
Why?
|
Aniline Compounds | 2 | 2011 | 1094 | 0.250 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2016 | 172 | 0.250 |
Why?
|
Editorial Policies | 2 | 2021 | 459 | 0.250 |
Why?
|
Blood-Brain Barrier | 5 | 2014 | 1033 | 0.240 |
Why?
|
Heart | 2 | 2017 | 4449 | 0.230 |
Why?
|
Macaca mulatta | 7 | 2024 | 2362 | 0.230 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2018 | 10776 | 0.230 |
Why?
|
Carbon Isotopes | 5 | 2017 | 458 | 0.220 |
Why?
|
Methylation | 3 | 2017 | 1076 | 0.220 |
Why?
|
Histone Demethylases | 2 | 2016 | 322 | 0.220 |
Why?
|
Bipolar Disorder | 2 | 2020 | 5126 | 0.220 |
Why?
|
Receptors, Opioid, mu | 1 | 2025 | 171 | 0.220 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2011 | 419 | 0.220 |
Why?
|
Capillary Permeability | 2 | 2019 | 773 | 0.220 |
Why?
|
Adult | 42 | 2024 | 223640 | 0.220 |
Why?
|
Schizophrenia | 3 | 2018 | 6987 | 0.220 |
Why?
|
Nuclear Proteins | 2 | 2024 | 5800 | 0.210 |
Why?
|
Glucose | 2 | 2023 | 4352 | 0.210 |
Why?
|
Zebrafish Proteins | 2 | 2019 | 1019 | 0.210 |
Why?
|
Spinal Cord | 3 | 2022 | 1813 | 0.210 |
Why?
|
Dopamine Antagonists | 5 | 2015 | 289 | 0.200 |
Why?
|
Spinal Nerves | 1 | 2022 | 92 | 0.200 |
Why?
|
Female | 55 | 2024 | 397089 | 0.200 |
Why?
|
Gadolinium | 1 | 2007 | 965 | 0.200 |
Why?
|
Drug Design | 5 | 2015 | 1046 | 0.200 |
Why?
|
Depressive Disorder, Major | 4 | 2024 | 4819 | 0.200 |
Why?
|
Kidney | 2 | 2014 | 7064 | 0.190 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 2021 | 39 | 0.190 |
Why?
|
Cerebrovascular Circulation | 4 | 2021 | 2736 | 0.190 |
Why?
|
Radioligand Assay | 2 | 2014 | 367 | 0.190 |
Why?
|
Neuronal Plasticity | 2 | 2023 | 1448 | 0.190 |
Why?
|
Fentanyl | 1 | 2025 | 450 | 0.190 |
Why?
|
Thalamus | 3 | 2024 | 1050 | 0.190 |
Why?
|
Cyclization | 2 | 2014 | 59 | 0.190 |
Why?
|
Enzyme Inhibitors | 4 | 2016 | 3722 | 0.190 |
Why?
|
Brain Diseases | 2 | 2021 | 1552 | 0.180 |
Why?
|
Protein Binding | 6 | 2019 | 9343 | 0.180 |
Why?
|
Frontotemporal Dementia | 1 | 2024 | 249 | 0.180 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2020 | 9063 | 0.180 |
Why?
|
Zebrafish | 3 | 2022 | 3037 | 0.180 |
Why?
|
Corpus Striatum | 4 | 2021 | 1237 | 0.180 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2014 | 2056 | 0.180 |
Why?
|
Motor Cortex | 2 | 2019 | 1014 | 0.170 |
Why?
|
Proteins | 3 | 2016 | 6006 | 0.170 |
Why?
|
Young Adult | 17 | 2024 | 60049 | 0.170 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 530 | 0.170 |
Why?
|
Blood Glucose | 1 | 2014 | 6430 | 0.170 |
Why?
|
Glycolysis | 1 | 2023 | 838 | 0.160 |
Why?
|
Motor Neurons | 3 | 2022 | 872 | 0.160 |
Why?
|
Triazoles | 3 | 2016 | 904 | 0.160 |
Why?
|
Sulfhydryl Compounds | 2 | 2017 | 296 | 0.160 |
Why?
|
Aging | 3 | 2017 | 8764 | 0.160 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2024 | 256 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2021 | 3781 | 0.160 |
Why?
|
Chromosome Disorders | 1 | 2021 | 499 | 0.160 |
Why?
|
Drug Discovery | 2 | 2016 | 1067 | 0.160 |
Why?
|
Food | 1 | 2023 | 768 | 0.150 |
Why?
|
Clioquinol | 1 | 2018 | 23 | 0.150 |
Why?
|
Transcription Factors | 2 | 2024 | 12166 | 0.150 |
Why?
|
Microglia | 3 | 2022 | 1374 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Antagonists | 1 | 2017 | 9 | 0.150 |
Why?
|
Drug Partial Agonism | 1 | 2017 | 24 | 0.150 |
Why?
|
Myocytes, Cardiac | 2 | 2017 | 1685 | 0.150 |
Why?
|
Spinal Nerve Roots | 1 | 2018 | 122 | 0.150 |
Why?
|
Biomedical Engineering | 1 | 2019 | 286 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 42 | 0.150 |
Why?
|
Hypercapnia | 2 | 2021 | 260 | 0.150 |
Why?
|
Receptors, Islet Amyloid Polypeptide | 1 | 2017 | 2 | 0.140 |
Why?
|
Dihydrotestosterone | 1 | 2018 | 195 | 0.140 |
Why?
|
Encephalitis | 2 | 2019 | 441 | 0.140 |
Why?
|
Contrast Media | 2 | 2008 | 5336 | 0.140 |
Why?
|
Periodicals as Topic | 2 | 2019 | 1469 | 0.140 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 2002 | 0.140 |
Why?
|
Glucans | 1 | 2017 | 71 | 0.140 |
Why?
|
Middle Aged | 30 | 2024 | 223491 | 0.140 |
Why?
|
Technology, Pharmaceutical | 1 | 2016 | 84 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11854 | 0.130 |
Why?
|
Case-Control Studies | 7 | 2021 | 22296 | 0.130 |
Why?
|
Synaptophysin | 1 | 2016 | 140 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2024 | 558 | 0.130 |
Why?
|
Tetrahydronaphthalenes | 1 | 2016 | 86 | 0.130 |
Why?
|
Nucleus Accumbens | 2 | 2017 | 373 | 0.130 |
Why?
|
Nerve Net | 3 | 2024 | 2362 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 2 | 2014 | 466 | 0.130 |
Why?
|
Brain Neoplasms | 2 | 2019 | 9198 | 0.130 |
Why?
|
Quinpirole | 1 | 2015 | 32 | 0.130 |
Why?
|
Radiculopathy | 1 | 2018 | 203 | 0.130 |
Why?
|
Multiple Sclerosis | 2 | 2024 | 3247 | 0.130 |
Why?
|
Pilot Projects | 6 | 2024 | 8731 | 0.130 |
Why?
|
Disease Models, Animal | 7 | 2017 | 18362 | 0.130 |
Why?
|
Behavior, Animal | 3 | 2017 | 1879 | 0.130 |
Why?
|
Dopamine Agonists | 2 | 2015 | 353 | 0.130 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2018 | 554 | 0.130 |
Why?
|
RNA, Viral | 1 | 2004 | 2866 | 0.130 |
Why?
|
Phenyl Ethers | 1 | 2015 | 62 | 0.120 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2016 | 113 | 0.120 |
Why?
|
tau Proteins | 3 | 2022 | 2143 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2016 | 1959 | 0.120 |
Why?
|
Cytoprotection | 1 | 2015 | 200 | 0.120 |
Why?
|
Manganese | 2 | 2015 | 394 | 0.120 |
Why?
|
Models, Chemical | 4 | 2014 | 611 | 0.120 |
Why?
|
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) | 1 | 2014 | 6 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1195 | 0.120 |
Why?
|
Motor Activity | 4 | 2014 | 2720 | 0.120 |
Why?
|
Tropanes | 2 | 2011 | 48 | 0.120 |
Why?
|
Cannabis | 1 | 2021 | 445 | 0.120 |
Why?
|
Injections, Intravenous | 3 | 2017 | 1379 | 0.120 |
Why?
|
Whole Body Imaging | 1 | 2017 | 284 | 0.120 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 129 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2017 | 796 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 2 | 2016 | 395 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2024 | 1658 | 0.110 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2014 | 64 | 0.110 |
Why?
|
Zinc | 1 | 2018 | 677 | 0.110 |
Why?
|
Drug Approval | 1 | 2021 | 818 | 0.110 |
Why?
|
Cerebral Cortex | 4 | 2024 | 5831 | 0.110 |
Why?
|
Object Attachment | 1 | 2017 | 333 | 0.110 |
Why?
|
Publishing | 1 | 2021 | 836 | 0.110 |
Why?
|
Fibromyalgia | 1 | 2018 | 407 | 0.110 |
Why?
|
Trimethylsilyl Compounds | 1 | 2013 | 8 | 0.110 |
Why?
|
Sodium Iodide | 1 | 2013 | 11 | 0.110 |
Why?
|
Benzofurans | 1 | 2014 | 139 | 0.110 |
Why?
|
Cesium | 1 | 2013 | 36 | 0.110 |
Why?
|
Carbonates | 1 | 2013 | 21 | 0.110 |
Why?
|
Amidohydrolases | 1 | 2014 | 160 | 0.110 |
Why?
|
Affect | 2 | 2013 | 1501 | 0.110 |
Why?
|
Time | 1 | 2015 | 546 | 0.110 |
Why?
|
Analgesia | 1 | 2017 | 460 | 0.110 |
Why?
|
Chromatography, Liquid | 2 | 2014 | 997 | 0.110 |
Why?
|
Oxidoreductases | 1 | 2015 | 412 | 0.110 |
Why?
|
Oxazoles | 1 | 2014 | 199 | 0.110 |
Why?
|
Isonicotinic Acids | 1 | 2012 | 7 | 0.110 |
Why?
|
Mother-Child Relations | 1 | 2017 | 501 | 0.100 |
Why?
|
Pyrazoles | 2 | 2021 | 2021 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 2 | 2015 | 1929 | 0.100 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2013 | 116 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1672 | 0.100 |
Why?
|
Unconsciousness | 1 | 2014 | 251 | 0.100 |
Why?
|
Computers | 1 | 2015 | 592 | 0.100 |
Why?
|
Heart Failure | 1 | 2017 | 11858 | 0.100 |
Why?
|
Metals | 1 | 2017 | 713 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 607 | 0.100 |
Why?
|
Elementary Particles | 1 | 2012 | 50 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 905 | 0.100 |
Why?
|
Image Enhancement | 2 | 2017 | 2894 | 0.100 |
Why?
|
Benzazepines | 1 | 2014 | 311 | 0.100 |
Why?
|
Nickel | 1 | 2012 | 126 | 0.100 |
Why?
|
Half-Life | 1 | 2013 | 650 | 0.100 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 697 | 0.100 |
Why?
|
Up-Regulation | 2 | 2021 | 4142 | 0.100 |
Why?
|
Locomotion | 2 | 2018 | 390 | 0.100 |
Why?
|
HeLa Cells | 2 | 2016 | 3088 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1248 | 0.100 |
Why?
|
Huntington Disease | 1 | 2018 | 1147 | 0.090 |
Why?
|
Platinum | 1 | 2012 | 222 | 0.090 |
Why?
|
Aged | 18 | 2024 | 171562 | 0.090 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2708 | 0.090 |
Why?
|
Aminophenols | 1 | 2011 | 87 | 0.090 |
Why?
|
Hydrazines | 1 | 2012 | 223 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1642 | 0.090 |
Why?
|
Brain Concussion | 1 | 2022 | 1433 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 505 | 0.090 |
Why?
|
Diffusion Tensor Imaging | 2 | 2018 | 2426 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2059 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1982 | 0.090 |
Why?
|
Ligands | 2 | 2017 | 3283 | 0.090 |
Why?
|
Anilides | 2 | 2013 | 414 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3458 | 0.090 |
Why?
|
Basal Ganglia | 1 | 2013 | 555 | 0.090 |
Why?
|
Mice | 14 | 2025 | 82017 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1279 | 0.080 |
Why?
|
Receptors, Vasopressin | 1 | 2010 | 106 | 0.080 |
Why?
|
Structure-Activity Relationship | 3 | 2022 | 3055 | 0.080 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2201 | 0.080 |
Why?
|
Synapses | 1 | 2019 | 1766 | 0.080 |
Why?
|
Memory, Short-Term | 1 | 2016 | 1010 | 0.080 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 739 | 0.080 |
Why?
|
Tissue Donors | 1 | 2019 | 2389 | 0.080 |
Why?
|
Action Potentials | 1 | 2017 | 1838 | 0.080 |
Why?
|
Neural Pathways | 2 | 2024 | 3121 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3610 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11918 | 0.080 |
Why?
|
Azabicyclo Compounds | 1 | 2009 | 68 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20224 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3906 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 413 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2276 | 0.080 |
Why?
|
Aromatase | 1 | 2009 | 147 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2537 | 0.080 |
Why?
|
Oxidation-Reduction | 3 | 2012 | 2225 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2846 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1695 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 22355 | 0.080 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 899 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2363 | 0.080 |
Why?
|
Benzaldehydes | 1 | 2008 | 59 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1974 | 0.070 |
Why?
|
Nicotinic Agonists | 1 | 2010 | 266 | 0.070 |
Why?
|
Spin Labels | 2 | 2021 | 339 | 0.070 |
Why?
|
Coumarins | 1 | 2008 | 119 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2020 | 5313 | 0.070 |
Why?
|
Sleep | 1 | 2023 | 4802 | 0.070 |
Why?
|
Metabolism | 1 | 2009 | 193 | 0.070 |
Why?
|
Methods | 1 | 2008 | 1067 | 0.070 |
Why?
|
Emotions | 1 | 2019 | 2768 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3623 | 0.070 |
Why?
|
Cocaine | 2 | 2009 | 960 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20765 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2819 | 0.070 |
Why?
|
Oximes | 1 | 2008 | 303 | 0.070 |
Why?
|
Neurogenesis | 1 | 2013 | 864 | 0.070 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1429 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4414 | 0.070 |
Why?
|
Cisplatin | 1 | 2012 | 1661 | 0.070 |
Why?
|
Fibroblasts | 1 | 2017 | 4177 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 7463 | 0.070 |
Why?
|
Psychotic Disorders | 2 | 2018 | 3279 | 0.070 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2139 | 0.070 |
Why?
|
Sodium Chloride | 2 | 2018 | 584 | 0.060 |
Why?
|
Light | 1 | 2012 | 1354 | 0.060 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 519 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1664 | 0.060 |
Why?
|
Receptors, Opioid | 2 | 2017 | 145 | 0.060 |
Why?
|
Molecular Weight | 1 | 2008 | 2172 | 0.060 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 461 | 0.060 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2012 | 846 | 0.060 |
Why?
|
Blotting, Western | 1 | 2013 | 5037 | 0.060 |
Why?
|
Solvents | 2 | 2022 | 298 | 0.060 |
Why?
|
Antirheumatic Agents | 1 | 2015 | 1377 | 0.060 |
Why?
|
Staphylococcal Infections | 1 | 2014 | 1398 | 0.060 |
Why?
|
Antidepressive Agents | 2 | 2014 | 2913 | 0.060 |
Why?
|
Nanoparticles | 1 | 2017 | 1987 | 0.060 |
Why?
|
Nicotine | 1 | 2010 | 680 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1713 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3230 | 0.060 |
Why?
|
Oxygen | 1 | 2016 | 4273 | 0.060 |
Why?
|
Piperazines | 1 | 2015 | 2552 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2018 | 3080 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3526 | 0.060 |
Why?
|
Phenols | 2 | 2020 | 520 | 0.060 |
Why?
|
Cues | 1 | 2009 | 884 | 0.060 |
Why?
|
Adolescent | 7 | 2024 | 89184 | 0.060 |
Why?
|
Genotype | 2 | 2016 | 13042 | 0.060 |
Why?
|
Protein Conformation | 2 | 2018 | 3955 | 0.050 |
Why?
|
Pain | 2 | 2018 | 5103 | 0.050 |
Why?
|
Putamen | 2 | 2018 | 293 | 0.050 |
Why?
|
Explosions | 1 | 2023 | 107 | 0.050 |
Why?
|
Dogs | 1 | 2008 | 3846 | 0.050 |
Why?
|
Particle Size | 1 | 2007 | 1653 | 0.050 |
Why?
|
Catalysis | 2 | 2015 | 768 | 0.050 |
Why?
|
Time Factors | 6 | 2015 | 40272 | 0.050 |
Why?
|
Nanostructures | 1 | 2008 | 553 | 0.050 |
Why?
|
Bioreactors | 1 | 2004 | 246 | 0.050 |
Why?
|
Nasal Cavity | 1 | 2024 | 311 | 0.050 |
Why?
|
Anxiety | 2 | 2025 | 4677 | 0.050 |
Why?
|
Diagnostic Imaging | 2 | 2018 | 3541 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18471 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2257 | 0.050 |
Why?
|
Benzhydryl Compounds | 1 | 2009 | 940 | 0.050 |
Why?
|
Fluoroacetates | 2 | 2013 | 14 | 0.050 |
Why?
|
United States | 4 | 2024 | 73150 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8615 | 0.050 |
Why?
|
Presenilin-1 | 2 | 2017 | 665 | 0.050 |
Why?
|
Depression | 3 | 2025 | 8241 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3838 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5796 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8753 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2014 | 3736 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14737 | 0.050 |
Why?
|
Chromatin | 1 | 2013 | 2968 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4788 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2010 | 1391 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9433 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 1952 | 0.040 |
Why?
|
Hot Temperature | 1 | 2007 | 1440 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2017 | 1114 | 0.040 |
Why?
|
Nucleic Acid Conformation | 1 | 2004 | 900 | 0.040 |
Why?
|
Astrocytes | 2 | 2018 | 1349 | 0.040 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2021 | 205 | 0.040 |
Why?
|
Central Nervous System Stimulants | 1 | 2009 | 1181 | 0.040 |
Why?
|
Hippocampus | 1 | 2013 | 3784 | 0.040 |
Why?
|
Viral Proteins | 1 | 2007 | 1802 | 0.040 |
Why?
|
Swine | 2 | 2020 | 5994 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2019 | 26375 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.040 |
Why?
|
Cognition | 2 | 2024 | 7075 | 0.040 |
Why?
|
Cyclic GMP | 1 | 2020 | 394 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4748 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7211 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 396 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 376 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2014 | 10478 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2017 | 36 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 14154 | 0.040 |
Why?
|
Phencyclidine | 1 | 2017 | 59 | 0.040 |
Why?
|
Authorship | 1 | 2021 | 289 | 0.040 |
Why?
|
Thalamic Nuclei | 1 | 2018 | 111 | 0.040 |
Why?
|
Coordination Complexes | 1 | 2018 | 73 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 2017 | 173 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2019 | 698 | 0.040 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2017 | 41 | 0.040 |
Why?
|
Atrophy | 1 | 2022 | 1648 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2012 | 1539 | 0.040 |
Why?
|
Models, Molecular | 3 | 2014 | 5404 | 0.030 |
Why?
|
Globus Pallidus | 1 | 2018 | 250 | 0.030 |
Why?
|
Gene Expression | 1 | 2009 | 7598 | 0.030 |
Why?
|
Imidazolines | 1 | 2016 | 18 | 0.030 |
Why?
|
Retinoid X Receptors | 1 | 2016 | 91 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 41795 | 0.030 |
Why?
|
Adenosine | 1 | 2021 | 817 | 0.030 |
Why?
|
Signal Transduction | 2 | 2018 | 23631 | 0.030 |
Why?
|
Disulfiram | 1 | 2016 | 63 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6234 | 0.030 |
Why?
|
Perfusion | 1 | 2021 | 1402 | 0.030 |
Why?
|
Blood Proteins | 2 | 2013 | 1186 | 0.030 |
Why?
|
Cortical Spreading Depression | 1 | 2020 | 288 | 0.030 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 188 | 0.030 |
Why?
|
Histones | 2 | 2019 | 2592 | 0.030 |
Why?
|
Prochlorperazine | 1 | 2015 | 16 | 0.030 |
Why?
|
Diagnosis | 1 | 2016 | 156 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2106 | 0.030 |
Why?
|
Methamphetamine | 1 | 2017 | 167 | 0.030 |
Why?
|
Escherichia coli | 2 | 2007 | 4211 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1169 | 0.030 |
Why?
|
Decarboxylation | 1 | 2015 | 8 | 0.030 |
Why?
|
Skull | 1 | 2020 | 831 | 0.030 |
Why?
|
Iodobenzenes | 1 | 2015 | 23 | 0.030 |
Why?
|
Publications | 1 | 2018 | 196 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11221 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2017 | 452 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16028 | 0.030 |
Why?
|
Interferon Inducers | 1 | 2014 | 24 | 0.030 |
Why?
|
Maze Learning | 1 | 2017 | 484 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18048 | 0.030 |
Why?
|
Diprenorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
Electrons | 1 | 2016 | 264 | 0.030 |
Why?
|
Ethylenediamines | 1 | 2014 | 57 | 0.030 |
Why?
|
Disulfides | 1 | 2016 | 467 | 0.030 |
Why?
|
Muscle Strength | 1 | 2018 | 641 | 0.030 |
Why?
|
Ions | 1 | 2015 | 256 | 0.030 |
Why?
|
Water | 2 | 2012 | 1418 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2226 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1013 | 0.030 |
Why?
|
Butyric Acid | 1 | 2013 | 52 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2124 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 947 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2085 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 606 | 0.030 |
Why?
|
Endocannabinoids | 1 | 2014 | 113 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9562 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1668 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2019 | 12805 | 0.030 |
Why?
|
Drug Interactions | 1 | 2017 | 1420 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 742 | 0.030 |
Why?
|
Drug Evaluation | 1 | 2014 | 642 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 2012 | 212 | 0.030 |
Why?
|
Oxytocin | 1 | 2017 | 403 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2012 | 199 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 17135 | 0.030 |
Why?
|
Firefly Luciferin | 1 | 2012 | 7 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1339 | 0.030 |
Why?
|
Iodine | 1 | 2015 | 286 | 0.030 |
Why?
|
Carbon | 1 | 2016 | 672 | 0.030 |
Why?
|
Paroxetine | 1 | 2013 | 181 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1084 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 4588 | 0.020 |
Why?
|
Prevalence | 2 | 2022 | 15872 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1135 | 0.020 |
Why?
|
Cysteine | 1 | 2016 | 895 | 0.020 |
Why?
|
Waist Circumference | 1 | 2015 | 935 | 0.020 |
Why?
|
Ketamine | 1 | 2017 | 525 | 0.020 |
Why?
|
Permeability | 1 | 2013 | 726 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 371 | 0.020 |
Why?
|
Solutions | 1 | 2012 | 409 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12241 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13503 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2017 | 2695 | 0.020 |
Why?
|
History, 21st Century | 1 | 2017 | 1575 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2445 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2011 | 455 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1053 | 0.020 |
Why?
|
Valproic Acid | 1 | 2013 | 443 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2012 | 343 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4781 | 0.020 |
Why?
|
Lithium | 1 | 2013 | 600 | 0.020 |
Why?
|
Dexmedetomidine | 1 | 2014 | 320 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12456 | 0.020 |
Why?
|
Pyrazinamide | 1 | 2010 | 60 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6607 | 0.020 |
Why?
|
Comorbidity | 1 | 2025 | 10588 | 0.020 |
Why?
|
Reward | 1 | 2017 | 984 | 0.020 |
Why?
|
Hydrocarbons, Iodinated | 1 | 2009 | 8 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 768 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 591 | 0.020 |
Why?
|
Injections | 1 | 2012 | 840 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2025 | 3743 | 0.020 |
Why?
|
Alkylation | 1 | 2009 | 84 | 0.020 |
Why?
|
History, 20th Century | 1 | 2017 | 2771 | 0.020 |
Why?
|
Consciousness | 1 | 2014 | 602 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1895 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1496 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1961 | 0.020 |
Why?
|
Isoniazid | 1 | 2010 | 288 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4049 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2009 | 612 | 0.020 |
Why?
|
Intracellular Space | 1 | 2009 | 199 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6241 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2528 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 4936 | 0.020 |
Why?
|
Artifacts | 1 | 2017 | 1930 | 0.020 |
Why?
|
Rifampin | 1 | 2010 | 345 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1226 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2009 | 392 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2025 | 7453 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3581 | 0.020 |
Why?
|
Diffusion | 1 | 2009 | 818 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2007 | 242 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4199 | 0.020 |
Why?
|
Thorax | 1 | 2010 | 559 | 0.020 |
Why?
|
Micelles | 1 | 2007 | 191 | 0.020 |
Why?
|
Chelating Agents | 1 | 2008 | 385 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30228 | 0.020 |
Why?
|
Protons | 1 | 2011 | 1112 | 0.020 |
Why?
|
Space Perception | 1 | 2009 | 467 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2820 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3632 | 0.020 |
Why?
|
Solubility | 1 | 2007 | 1085 | 0.020 |
Why?
|
Biotechnology | 1 | 2007 | 283 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1813 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1167 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6510 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2017 | 5151 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6808 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13423 | 0.010 |
Why?
|
Arteries | 1 | 2009 | 1126 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3411 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6277 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22385 | 0.010 |
Why?
|
Learning | 1 | 2013 | 1761 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17626 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6017 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59686 | 0.010 |
Why?
|
Tuberculosis | 1 | 2015 | 2029 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5801 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15597 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1195 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14481 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 54920 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19022 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13646 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15939 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13084 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9516 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7599 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 30200 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6317 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 30022 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13052 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2007 | 3413 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36510 | 0.010 |
Why?
|
Neurons | 1 | 2013 | 9513 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 81801 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9493 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2009 | 4429 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65379 | 0.010 |
Why?
|